Synta Pharmaceuticals (SNTA) Catches Eye: Stock Rises 8.9%

Zacks

Synta Pharmaceuticals Corp. (SNTA) was a big mover last session with its shares rising nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock has gained nearly 41% since Feb 3.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Synta Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked biomedical stocks include Alexion Pharmaceuticals, Inc. (ALXN), Biogen Idec Inc. (BIIB) and Actelion Ltd. (ALIOF). While Alexion and Biogen sport a Zacks Rank #1 (Strong Buy), Actelion carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



SYNTA PHARMACEUTICALS INC (SNTA): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)